Appointments at Catalent, Novella and Publicis – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Novella and Publicis.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Catalent, Novella and Publicis.
Elan Drug Technologies’ (EDT) revenues dropped in the first quarter as generic competition wiped out Skelaxin (metaxalone) earnings.
Gilead has entered into a licence and collaboration agreement with drug delivery specialists MicroDose Therapeutx to develop a treatment for respiratory syncytial virus (RSV).
China-based Hebei Aoxing is to produce naloxone hydrochloride API after it successfully adopted new drug processing technology.
Video News in Brief
Industrial PC supplier Noax says pharmaceutical industry demand for sealed computers is growing and being driven by increasing regulatory focus on containment in manufacturing processes.
Icon posted a big drop in operating income in the first quarter and has allied with Japan-based Acronet to expand geographic reach.